+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CORONA

Corona Remedies Share Price

 

 

Corona Remedies live price: ₹2022.8. It opened at ₹1,985 vs previous close ₹1,979; intraday high/low: ₹2,046/₹1,985. The 50 DMA stands at ₹1,809.43.

Corona Remedies Performance

  • Today's Low
  • ₹1,985
  • Today's High
  • ₹2,046
  • 52 Week Low
  • ₹1,337
  • 52 Week High
  • ₹2,101
  • Open Price₹1,985
  • Previous Close₹1,979
  • Volume11,366
  • 50 DMA₹1,809.43
  • 100 DMA₹1,701.45
  • 200 DMA-

Corona Remedies Chart

Investment Returns

  • Over 1 Month + 16.21%
  • Over 3 Month + 30.11%
  • Over 6 Month + 38.26%
  • Over 1 Year + 90.47%

Smart Investing Starts Here Start SIP with Corona Remedies for Steady Growth!

Invest Now

Corona Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 66.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 12,372
  • P/B Ratio
  • 16.6
  • Average True Range
  • 77.24
  • EPS
  • 32.68
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 67.63
  • RSI
  • 67.16
  • MFI
  • 81.35

Latest Stock News Updates

Corona Remedies inaugurates women's hormone manufacturing facility in Ahmedabad

The integrated manufacturing unit will produce multiple dosage formsincluding tablets, soft gel capsules, ointments and gelswithin a single manufacturing ecosystem

ADIA, Aberdeen Group, others buy 7.3% stake in Corona Remedies for 777 crore

Following the stake purchase, shares of Corona Remedies rose nearly 3 per cent on Thursday to trade at 1,840 apiece on the National Stock Exchange (NSE).

Corona Remedies Results Earnings Call for Q4FY26 & Full Year

Conference Call with Corona Remedies Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Corona Remedies Financials

Corona Remedies Technicals

EMA & SMA

Current Price
₹2,022.80
+ 43.4 (2.19%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹1,916.20
  • 50 Day
  • ₹1,809.40
  • 100 Day
  • ₹1,701.40
  • 200 Day
  • -

Resistance and Support

2017.93 Pivot Speed
  • R3 2,112.17
  • R2 2,079.13
  • R1 2,050.97
  • S1 1,989.77
  • S2 1,956.73
  • S3 1,928.57

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Corona Remedies Limited is a fast-growing Indian pharmaceutical company focused on women’s healthcare, cardio-diabeto, pain management, and urology. It operates two manufacturing facilities in Gujarat and Himachal Pradesh with 11 production lines and EU-GMP/WHO-GMP certifications.

Corona Remedies Ltd has an operating revenue of Rs. 1,403.18 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 17% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 23% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 28 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Corona Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-11 Audited Results & Final Dividend
2026-02-02 Quarterly Results
2026-01-02 Quarterly Results Inter-alia, to consider and approve the financial results for the period ended September 30, 2025 per share(100%)Final Dividend
Date Purpose Remarks
2026-06-19 FINAL Rs.10.00 per share(100%)Final Dividend
View Corona Remedies Dividend History Arrow

Corona Remedies Shareholding Pattern

69%
6.35%
0.58%
2.25%
0%
0.77%
21.05%

Corona Remedies FAQs

Corona Remedies share price is ₹2,022 As on 09 July, 2026 | 18:01

The Market Cap of Corona Remedies is ₹12371.5 Cr As on 09 July, 2026 | 18:01

The P/E ratio of Corona Remedies is 66.8 As on 09 July, 2026 | 18:01

The PB ratio of Corona Remedies is 16.6 As on 09 July, 2026 | 18:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23